We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMNL
4776
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$52K ﹤0.01%
2,274
+844
+59% +$24.3K
MBAI
4777
Check-Cap
MBAI
$1.32M
$51K ﹤0.01%
419
CHR icon
4778
Cheer Holding
CHR
$3.58M
$50K ﹤0.01%
21
RNAZ icon
4779
TransCode Therapeutics
RNAZ
$3.63M
0
ALJJ
4780
DELISTED
ALJ Regional Holdings Inc
ALJJ
$50K ﹤0.01%
47,893
NBRV
4781
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$50K ﹤0.01%
1,710
+867
+103% +$24.5K
AKTX
4782
Akari Therapeutics
AKTX
$13.5M
$49K ﹤0.01%
38
IFRX icon
4783
InflaRx
IFRX
$295M
$49K ﹤0.01%
+18,991
New +$50K
IKT icon
4784
Inhibikase Therapeutics
IKT
$385M
$49K ﹤0.01%
+4,306
New +$58.2K
GMDA
4785
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$49K ﹤0.01%
12,700
-18,557
-59% -$92.8K
HUSN
4786
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$49K ﹤0.01%
9,059
+1,468
+19% +$9.45K
PRHI
4787
Presurance Holdings
PRHI
$17M
$48K ﹤0.01%
2,387
FAMI icon
4788
Farmmi Inc
FAMI
$6.26M
$48K ﹤0.01%
43
SNT
4789
Senstar Technologies
SNT
$44.8M
$48K ﹤0.01%
12,188
TAIT
4790
DELISTED
Taitron Components
TAIT
$48K ﹤0.01%
12,619
VRPX
4791
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$48K ﹤0.01%
+40
New +$83.8K
PTPI
4792
DELISTED
Petros Pharmaceuticals
PTPI
$47K ﹤0.01%
95
SIFY
4793
Sify Technologies
SIFY
$1.13B
$46K ﹤0.01%
2,284
NVOS
4794
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$46K ﹤0.01%
2,467
+481
+24% +$9.48K
ZNB
4795
Zeta Network Group
ZNB
$2.57M
0
TAOP icon
4796
Taoping
TAOP
$8.24M
$45K ﹤0.01%
+57
New +$57.4K
CIH
4797
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$45K ﹤0.01%
30,851
LFWD icon
4798
ReWalk Robotics
LFWD
$21.3M
$44K ﹤0.01%
353
IRCP
4799
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$44K ﹤0.01%
+15,135
New +$39.2K
RCON icon
4800
Recon Technology
RCON
$2.81M
$42K ﹤0.01%
840
+173
+26% +$10K

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.